OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
Kevin J. Selva, Pradhipa Ramanathan, Ebene R. Haycroft, et al.
JCI Insight (2023) Vol. 8, Iss. 18
Open Access | Times Cited: 11

Showing 11 citing articles:

Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
Alberto Rubio‐Casillas, David E. Cowley, Mikolaj Raszek, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131427-131427
Closed Access | Times Cited: 10

Deciphering Fc-effector functions against SARS-CoV-2
Guillaume Beaudoin-Bussières, Andrés Finzi
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 756-768
Closed Access | Times Cited: 6

Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults
Anne T. Gelderloos, Marije K. Verheul, Irene Middelhof, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6

Randomised controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine
Wen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 5

Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant
L. Carissa Aurelia, Ruth A Purcell, Robert M. Theisen, et al.
Science Advances (2025) Vol. 11, Iss. 9
Closed Access

Does SARS-CoV-2 Possess “Allergen-Like” Epitopes?
Alberto Rubio‐Casillas, David E. Cowley, Vladimir N. Uversky, et al.
COVID (2025) Vol. 5, Iss. 4, pp. 55-55
Open Access

Exploring the possible link between the spike protein immunoglobulin G4 antibodies and cancer progression
Mikolaj Raszek, David E. Cowley, Elrashdy M. Redwan, et al.
Exploration of Immunology (2024), pp. 267-284
Open Access | Times Cited: 2

Current German Recommendations and International Research on the Use of COVID-19 Boosters among Health Care Providers in 2024: A Narrative Review
Poramate Pitak‐Arnnop, Popchai Ngamskulrungroj, Nithi Mahanonda, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 385-385
Open Access | Times Cited: 2

Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents
Ruth A Purcell, L. Carissa Aurelia, Robyn Esterbauer, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2

Viral infection and antiviral immunity in the oral cavity
Heather D. Hickman, Niki M. Moutsopoulos
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 2

Mechanisms and Implications of IgG4 Responses to SARS-CoV-2 and Other Repeatedly Administered Vaccines
Anthony M. Marchese, Louis Fries, Hadi Beyhaghi, et al.
Journal of Infection (2024), pp. 106317-106317
Open Access | Times Cited: 1

Page 1

Scroll to top